Navigation Links
Beckman Coulter Affirms 2009 Outlook
Date:12/17/2009

ng patient health and reducing the cost of care. Recurring revenue, consisting of consumable supplies (including reagent test kits), service and operating-type lease payments, represent about 78% of the company's 2008 revenue of $3.1 billion. For more information, visit www.beckmancoulter.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements contain words such as "achieve," "anticipate," "expect," "should," "continue," or the negative thereof or comparable terminology, and may include information regarding the company's expectations, achievements, goals or intentions regarding the future, including statements regarding expectations for earnings growth, adjusted earnings per share growth, anticipated total revenue, recurring revenue growth, anticipated cash instrument sales, expense management, the effects of ODS, adjusted operating income margin, non-operating expense, expense management, tax rate, share count, earnings per diluted share, impact, stability of our installed base and strength of our business model. The outlook provided is based on fiscal year ended 2008 and the quarter and nine months ended September 30, 2009 adjusted results and does not include special items that have occurred or may occur in 2009.

Forward-looking statements included in this press release involve certain risks and uncertainties and are based on management's current expectations, estimates, forecasts and projections about the company and are subject to risks and uncertainties, some of which may be beyond the company's control, that co
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Beckman Coulter to Present at the 2009 Piper Jaffray Healthcare Conference
2. Beckman Coulter Announces Conference Call and Webcast of Accompanying Slides in Conjunction With Third Quarter 2009 Earnings
3. Beckman Coulter Announces Third Quarter 2009 Results
4. Beckman Coulter to Present at Upcoming Healthcare Conferences
5. Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers
6. Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway
7. China-Biotics, Inc. Begins Trial Production at New Facility, Affirms 2010 Revenue Guidance
8. Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia
9. Accumetrics Closes 2009 with Positive Outlook
10. Reportlinker Adds Latin American Pharmaceutical Market Outlook to 2014: Policy environment, market analysis, forecasts and growth opportunities
11. Reportlinker Adds Direct to Consumer (DTC) Advertising in Pharmaceuticals - Current and Future Market Outlook, Regulatory Landscape and Case Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 21, 2014   Royal Philips (NYSE: ... it has received 510(k) clearance from the U.S. ... planning application for Transcatheter Aortic-Valve Implantation (TAVI) treatments. ... interventionalists with pre-procedural, high-precision positioning to treat aortic ... application is available as part of Philips ...
(Date:8/21/2014)... 2014 Asterias Biotherapeutics, Inc. (OTCBB: ASTY), a ... medicine, announced today the appointments of Andrew ("Andy") Arno ... Board of Directors. With these additions, the Asterias Board ... are independent. Andy Arno , 55, ... companies. He is currently Managing Director of Emerging Growth ...
(Date:8/20/2014)... Aug. 20, 2014  The National Association of ... results achieved by the real-time, pseudoephedrine (PSE) blocking ... Precursor Log Exchange (NPLEx), automatically blocks unlawful PSE ... meth offenders and make arrests. Data released by ... blocked the sale of more than ...
Breaking Medicine Technology:Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 2Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 2Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 3Asterias Biotherapeutics Appoints Two Independent Directors and Announces Completion of Series A Common Stock Distribution 4Indiana's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... a healthcare investment firm with offices in Palo Alto, ... of Vivo Ventures VII ("Vivo VII") at $375 million, ... more than $1 billion. Vivo plans ... pharmaceutical and medical device companies in the U.S. and ...
... Therapeutics, Inc. (NASDAQ: ECTE ), a ... a non-invasive, wireless, transdermal continuous glucose monitoring system ... delivery, today announced that Patrick T. Mooney, M.D., ... at the Biotech Showcase 2012 Conference. ...
Cached Medicine Technology:Vivo Ventures Closes $375 Million 7th Fund to Invest in Healthcare in the U.S. and Greater China 2Echo Therapeutics to Present at Biotech Showcase 2012 in San Francisco 2
(Date:8/22/2014)... For the fourth time, TharpeRobbins, a global leader ... received a prestigious level of recognition from Inc. Magazine. ... remains on the exclusive list of top 5000 fastest ... the list in 2010, 2011 and 2013. , ... list for a fourth time," says Brett Tharpe, CEO ...
(Date:8/22/2014)... Omaha, NE (PRWEB) August 22, 2014 ... has once again earned a position on the Inc. ... healthcare staffing company placed in position 1424 on the ... revenue of $126.2 million. This marks the seventh time ... earned a spot on the Inc. 5000, including one ...
(Date:8/22/2014)... Kicking blog MichaelHusted.com is featuring an interview ... his role as a kicking coach, his kicking business, and ... retired NFL kicker Michael Husted author of Husted Kicking.com. , ... him join our NCS Network,” says Husted. β€œHe brings a ... will continue to strengthen our coaching staff and the NCS ...
(Date:8/22/2014)... 2014 An increasing number of mergers ... in the market. M&As provide financial assistance to smaller ... rise the distribution channels of companies and help in ... markets. , According to the β€œ Global Animal Health ... and protein-rich diet is one of the major drivers ...
(Date:8/22/2014)... 2014 AttorneyOne.com, a recognized authority on ... information from the FDA on Diamondback 360 Peripheral ... announced on August 19, that certain lots of the ... (Part number 7-10003), by Cardiovascular Systems, are recalled ... could fracture during use and could possibly block blood ...
Breaking Medicine News(10 mins):Health News:For The Fourth Time - TharpeRobbins Earns A Place On Prestigious Inc. Magazine 500|5000 List 2Health News:For The Fourth Time - TharpeRobbins Earns A Place On Prestigious Inc. Magazine 500|5000 List 3Health News:Medical Solutions Earns Position on the 2014 Inc. 5000 List 2Health News:MichaelHusted.com Interviews Coach Brian Jackson of Team Jackson Kicking on His Role as a Kicking Coach, and on Becoming a National Camp Series (NCS) Associate 2Health News:MichaelHusted.com Interviews Coach Brian Jackson of Team Jackson Kicking on His Role as a Kicking Coach, and on Becoming a National Camp Series (NCS) Associate 3Health News:Global Animal Health Market 2014-2018 a New Research Report Added to ReportsnReports.com 2Health News:Global Animal Health Market 2014-2018 a New Research Report Added to ReportsnReports.com 3Health News:Global Animal Health Market 2014-2018 a New Research Report Added to ReportsnReports.com 4Health News:Diamondback 360 Peripheral Orbital Atherectomy System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 2
... in an extremely exciting phase right now. We are ... formed and are starting clinical trials in different areas," ... first-in-human study was just initiated for Parkinson,s disease patients ... NeuroNova. The drug, which is administered into the fluid-filled ...
... ST. PAUL, Minn., May 21 Three HealthEast ... agreed to pay the federal government a total ... tam") lawsuit alleging Medicare fraud involving a certain ... hospitals are the first hospitals to settle charges ...
... FRANCISCO -- Mayo Clinic researchers have found that bipolar ... as diabetes, depression, asthma or coronary artery disease. These ... claim costs. Specialty care costs (the costs of seeing ... for bipolar patients. Results of this review are being ...
... May 21 Elimination of funding for ... by the Senate Republican budget plan would end a ... rate of health care cost increases, improving quality of ... today.For the past two years the small "think tank" ...
... HMS today announced that it had been awarded contracts ... million lives to the company,s portfolio. HMS will be providing ... party recovery and cost avoidance -- to Citrus Health Care, ... (NY); Health First (NY); Health Plan of Michigan, Inc. (MI); ...
... (May 21, 2009) In comparing ultrasound with other medical ... review of published studies in the May/June issue of ... of ultrasound to provide an accurate diagnosis more cost ... the 1950s, ultrasound has been utilized mostly in hospital settings. ...
Cached Medicine News:Health News:Minnesota Hospitals Pay $2.28 Million to Settle Medicare Fraud Charges Involving Kyphoplasty 2Health News:Minnesota Hospitals Pay $2.28 Million to Settle Medicare Fraud Charges Involving Kyphoplasty 3Health News:Senate Republican Budget Would End Health Initiatives That Save Lives and Money 2Health News:Senate Republican Budget Would End Health Initiatives That Save Lives and Money 3Health News:Senate Republican Budget Would End Health Initiatives That Save Lives and Money 4
... The unique triple-mode technology ... all-around system for an array ... technology includes a patented, controllable ... mode for classical ablation procedures, ...
... Test is the only in-office test approved by ... The NMP22 BladderChek Test is a painless and ... that detects elevated levels of NMP22 protein. Healthy ... protein in the urine. However, the level of ...
ARION is a long-pulsed alexandrite laser system with a wavelength of 755 nm...
Used for measuring rectal pressure during urodynamic studies. All-silicone construction provides maximum softness and biocompatibility for enhanced patient comfort. Supplied sterile in peel-open pack...
Medicine Products: